News
Latest news + coverage.
Lab Automation: Overcoming Operational Friction with L7 Informatics
Lab Manager examines how L7|ESP® 2026.1 helps precision science organizations reduce operational friction created by fragmented systems. The article highlights L7|SYNAPSE™ agentic AI, major computation speed improvements, advanced NOR and PAR operational modeling, and flexible deployment options. It also explores how a unified platform can connect laboratory, manufacturing, and data workflows with greater operational context…
ReadL7 Informatics Unveils L7|ESP® 2026.1, Solidifying the Premier Agentic Operating System for Precision Sciences
L7 Informatics announced the general availability of L7|ESP 2026.1, solidifying the platform as the agentic operating system for precision science. The milestone release deploys the L7|SYNAPSE AI framework and its Seven chief agent, delivers major performance acceleration, and embeds NORs and PARs compliance modeling directly into manufacturing and asset management.
ReadL7 Informatics Names Ray Veeraraghavan, Ph.D., Vice President of Science and AI
L7 Informatics has named Ray Veeraraghavan, Ph.D., Vice President of Science and AI. A former Quest Diagnostics executive who led the enterprise evaluation that selected L7|ESP, Veeraraghavan will drive L7|SYNAPSE Agentic AI adoption, lead scientific content strategy, and advise senior leadership at L7's most strategic enterprise accounts.
ReadVasu Rangadass on Integrated Platforms for Regulated Industries
The Silicon Review features L7 Informatics and Vasu Rangadass, Ph.D., highlighting how L7|ESP helps regulated scientific organizations move beyond fragmented systems. The article explores AI-ready data, workflow orchestration, composable architecture, and the emergence of L7|SYNAPSE as an agentic AI layer for regulated scientific execution.
ReadEliminating Data Silos in High-Stakes CGT Manufacturing
In this Life Sciences Review article, Marcia Blackmoore discusses how L7|ESP eliminates data silos in cell and gene therapy manufacturing. The unified Enterprise Science Platform orchestrates workflows, batch records, and QC across the vein-to-vein lifecycle, delivering real-time process visibility, chain-of-identity traceability, and a scalable foundation for clinical and commercial operations.
ReadL7 Informatics Announces L7|SYNAPSE, Advancing Context-Aware AI for Regulated Scientific Execution
L7 Informatics announced the launch of L7|SYNAPSE™, an agentic AI layer built on the L7|ESP platform, designed to make artificial intelligence operationally reliable and secure in regulated life sciences environments. An article from IT DIGEST.
ReadL7 Informatics Announces L7|SYNAPSE, Advancing Context-Aware AI for Regulated Scientific Execution
L7 Informatics announced the launch of L7|SYNAPSE™, an agentic AI layer built on the L7|ESP platform, designed to make artificial intelligence operationally reliable and secure in regulated life sciences environments. An article from CIO First.
ReadL7 Informatics Announces L7|SYNAPSE™: Advancing Context-Aware AI for Regulated Scientific Execution
L7 Informatics announces L7|SYNAPSE, an agentic AI layer built on the L7|ESP platform that brings context-aware, compliance-ready AI to regulated life sciences operations. Grounded in organization-specific knowledge including SOPs, protocols, and batch records, L7|SYNAPSE enables natural language interaction with workflows, data, and systems across laboratory, quality, and manufacturing environments.
ReadLargest tech employers in the Austin area
L7 Informatics has been recognized by the Austin Business Journal as one of the largest tech employers in the Austin area. The company is recognized for its L7|ESP unified digital platform serving healthcare and life sciences organizations.
ReadArchitecting the Infrastructure Where Science Meets Strategy
In this Business Lens Media article, Dr. Vasu Rangadass, Founder and Strategy Officer at L7 Informatics, explores how unified enterprise science platforms are replacing fragmented point solutions in life sciences. From AI-actionable workflows to compliant data orchestration, his vision centers on building execution infrastructure that supports scientific innovation for decades, not just product cycles.
ReadL7 Informatics: The New Blueprint for Precision Medicine
As featured in Life Sciences Business Outlook, L7 Informatics is redefining how precision medicine scales by connecting scientific data across the full therapy lifecycle. With a unified platform that preserves context from research through manufacturing to patient delivery, L7 helps life sciences organizations move faster, stay compliant, and build the AI-ready foundation modern drug development…
ReadThe Top Women Leaders in Healthcare Technology of 2025
Marcia Blackmoore, Chief Commercial Officer of L7 Informatics, has been named a 2025 Top Women Leader in Healthcare Technology by The Healthcare Technology Report. The annual recognition highlights women driving progress across complex areas of healthcare technology and innovation. Congratulations to Marcia and all 2025 honorees.
ReadL7 Informatics and Turnberry Solutions Announce Strategic Teaming Agreement to Accelerate Life Sciences Innovation at Enterprise Scale
The L7 Informatics / Turnberry Solutions partnership establishes a strategic teaming agreement to deliver enterprise digital transformation for life sciences and food companies. By combining L7|ESP® with Turnberry’s delivery-certainty, cloud-exclusive services model, the collaboration supports multi-site implementations, predictable deployments, and faster time-to-value across research, development, and manufacturing.
ReadLeica Biosystems and L7 Informatics Announce Strategic Partnership to Develop the Next Generation of Informatics Solutions to Improve Operational Efficiency in Pathology Labs
Leica Biosystems and L7 Informatics announced a strategic partnership to develop next-generation pathology informatics solutions. The Leica and L7 partnership integrates Leica Biosystems' advanced instrumentation with L7|ESP to create unified, AI-ready infrastructure that automates and orchestrates workflows across the entire pathology laboratory.
ReadFrost & Sullivan TGL | Reimagining LIMS: How L7 Informatics is Accelerating the Next Wave of Digital Transformation
Frost & Sullivan’s Transformational Growth Leadership Program features L7 Informatics' Vasu Rangadass, Ph.D., in a discussion on how L7|ESP is redefining LIMS and digital transformation in life sciences. Rangadass discusses unified data models, workflow orchestration, AI readiness, and the operational foundations needed for faster development and modern, end-to-end scientific processes.
ReadL7 Informatics is Unifying Life Sciences: Breaking Down Data Silos to Accelerate the Future of Medicine
L7|ESP is a unified digital platform that eliminates data silos across pharmaceutical research, development, and manufacturing. By contextualizing and harmonizing data from disparate systems, L7 enables AI-ready operations and regulatory compliance while reducing time-to-market for new therapies. The Austin-based company has achieved four consecutive Deloitte Technology Fast 500 recognitions.
ReadL7 Informatics Named Top Innovator in 2025 Frost & Sullivan Frost Radar™ for Pharma and Biotech LIMS
Frost & Sullivan named L7 Informatics Global Leader in Innovation in its 2025 Frost Radar™ for Pharma and Biotech LIMS, citing L7|ESP® for its unified platform architecture, workflow orchestration, and AI-ready design. The recognition underscores L7’s vision to unify science and data across R&D, quality, and manufacturing.
ReadFrost Radar™ Identifies L7 Informatics as a Top Growth and Innovation Leader in Pharmaceutical and Biotech LIMS
Frost & Sullivan Frost Radar™ has named L7 Informatics a top innovator in Pharmaceutical and Biotech LIMS, 2025. The recognition highlights L7|ESP®’s role in creating AI-ready data through unified workflows and contextualized information, helping life sciences organizations accelerate research, manufacturing, and analytics with a digital backbone built for scalability and intelligence.
ReadL7 Informatics, Inc.: Digital Solutions for the Life Sciences Industry
International Business Times profiles L7 Informatics, an Austin-based company providing L7|ESP, a unified digital platform for life sciences organizations. The platform integrates laboratory information management, electronic notebooks, and manufacturing execution. Led by CEO Mark L. Spencer, L7 earned Gartner recognition and four consecutive Deloitte Technology Fast 500 rankings.
ReadCGT Outsourcing: Trends, Challenges, and Future Growth
This Contract Pharma article features insights from L7 Informatics on cell and gene therapy outsourcing. Learn about current trends, industry challenges, and the future of CGT manufacturing, with perspectives for CDMOs and biopharma leaders focused on innovation and digital transformation.
ReadPharma Matters Q&A: Building Smarter, Faster CDMOs: A Data-First Strategy for Advanced Therapies
Explore why a data-first approach is essential for CDMOs supporting advanced therapies. This Contract Pharma Q&A with L7's Marcia Blackmoore reveals how modern data platforms drive faster tech transfers, seamless collaboration, and compliance, equipping organizations to scale and innovate in an ever evolving biomanufacturing landscape.
ReadBioprocess Online: Keep An Eye On These Analytical And Monitoring Trends in 2025
Caraugh Albany, Charlie Wakeham, and Steven Erb weigh in on the upcoming industry advancements for 2025 in this Bioprocess Online article.
ReadOutsourced Pharma: Keep An Eye On These Analytical And Monitoring Trends in 2025
Outsourced Pharma features industry leaders Caraugh Albany, Charlie Wakeham, and Steven Erb as they share their thoughts on how the industry will build on progress in 2025.
ReadBiosimilar Development: Keep An Eye On These Analytical And Monitoring Trends in 2025
In this Biosimilar Development, industry leaders Caraugh Albany, Charlie Wakeham, and Steven Erb discuss their insights on how advancements in the field will evolve in 2025.
ReadLife Sciences’ Need for AI-Ready Data and Unifying Platform Places L7 Informatics on the Deloitte Technology Fast 500™ List for 4th Year Running
For the fourth year running, L7 has earned a spot on the Deloitte FAST 500 list, and we couldn't be more proud of it! This achievement reflects our ongoing commitment to solving life sciences’ biggest challenges with a single, unifying platform, L7|ESP®.
ReadL7 Informatics Partners with ZAETHER to Accelerate Digital Transformation in Life Sciences
The collaboration between L7 Informatics and ZAETHER is set to deliver comprehensive software, consulting, and support solutions that will empower life sciences leaders to drive transformative change with greater flexibility, adaptability, and speed to market.
ReadL7 Informatics Wins Gold in Learning and Development at the 2024 Brandon Hall Group HCM Excellence Awards™
L7 Informatics is proud to announce that it has won the coveted Gold award in the Learning and Development category for Best Training Team at the 2024 Brandon Hall Group HCM Excellence Awards™. This prestigious award, received on August 22, 2024, marks a significant achievement for L7 Informatics and underscores the commitment L7 makes to…
ReadCellipont Bioservices Selects L7 Informatics’ Manufacturing Platform
The deployment of L7|ESP by Cellipont optimizes cell therapy development and manufacturing processes.
ReadCellipont Bioservices Selects L7 Informatics For Its Flexible And Unified Platform, Enabling End-To-End Manufacturing
L7 Informatics is excited to announce a strategic partnership with Cellipont Bioservices. This collaboration marks a pivotal moment as Cellipont embraces L7 Informatics' L7|ESP™ unified platform and its integrated Manufacturing Execution System (MES) application to digitalize its cell therapy manufacturing recipes, streamline technology transfers, and digitally enable its customers.
ReadFor a 3rd Year Running, L7 Informatics Joins the Winner’s Circle Again, Making the 2023 Deloitte Technology Fast 500™
L7 Informatics proudly announces its inclusion in the prestigious Deloitte Technology Fast 500™, for the third consecutive year. This accolade celebrates the company's extraordinary 2047% revenue growth, a testament to its groundbreaking approach and unwavering commitment to the life sciences sector.
ReadL7 Informatics Manages and Supports the Entire Lab Workflow from Sample Processing to Data Analysis and Insight Generation Employing Workflow Orchestration
EnlightenBio’s “Company Spotlight” provides a closer look at L7 Informatics, the provider of a scientific process and data management (SPDM) solution to streamline and optimize lab processes and accelerate insights delivery for research, diagnostics, and therapeutics with the overall goal of better patient outcome.
ReadL7 Informatics Inc. Secures Silver in Prestigious Brandon Hall Group HCM Excellence Awards™
L7 Informatics wins the coveted 2023 Brandon Hall Group Silver Award for Excellence in the Best Customer Training Program category.
ReadL7 Informatics Expands European Operations to Strengthen Commitment to Pharmaceutical and Biotech Industries
L7 Informatics announces the expansion of its European operations, reinforcing its dedication to serving the pharmaceutical and biotech industries with advanced capabilities.
ReadL7 Informatics Supports Cancer Research at Dana Farber Cancer Institute with L7|ESP™
L7 Informatics announces the implementation of their flagship product, L7|ESP™ software, at the Connell and O'Reilly Families Cell Manipulation Core Facility (CMCF) of the prestigious Dana Farber Cancer Institute (DFCI).
ReadAchieving Digital Transformation: Unlocking Cost Reduction, Clinical Excellence & Precision Therapeutics Manufacturing
Explore how L7 Informatics leads the charge in driving digital transformation within the pharmaceutical and biotech industries. With a focus on cost reduction, clinical excellence, and precision therapeutics development and manufacturing, L7 Informatics revolutionizes traditional operations through cutting-edge digital solutions.
ReadL7’s Vasu Rangadass Is Creating Unified Systems in Healthcare
At L7 Informatics, Vasu Rangadass aims to reduce drug manufacturing costs, streamline operations, and, above all, help patients and providers alike.
ReadEmpowering Life Sciences While Reducing Operational Costs and Driving Efficiency
Read about L7 Informatics' modern approach: a unified platform system that can scale with your organization and requires fewer IT resources.
ReadDigital-First Implementation Breaks Down Data Silos to Solve Laboratory Data Management and Workflow Challenges
Integrated data platforms allow you to make better data-driven decisions for your lab. Vasu Rangadass, Ph.D., President and CEO of L7 Informatics is interviewed by Zahraa Chorghay, PhD, Today's Clinical Lab's clinical writer and editor.
ReadL7 and Tag.bio Team Up to Accelerate Digital Transformation
L7 is integrating Tag.bio's data mesh platform into its "life-leading unified platform," L7|ESP, and offering it to all existing and new customers.
ReadL7 Informatics Raises $38 Million Growth Investment to Digitalize Precision Healthcare
L7 Informatics announced a $38 million investment led by Banneker Partners with participation from its pre-existing investors.
ReadForbes: Why We Can’t Keep Doing Science In A Spreadsheet
In Forbes, John Cumbers argues that relying on spreadsheets for scientific research is unsustainable. He outlines critical limitations and explains why modern digital platforms are better suited for rigorous, collaborative science. The piece calls for moving beyond outdated tools toward cloud-native research infrastructure.
ReadThe Jackson Laboratory Goes Live with L7|ESP Data+Intelligence Unified Platform
L7 Informatics announced that The Jackson Laboratory (JAX) has gone live with the L7|ESP platform, providing the environment for scientists and engineers to co-innovate to improve process velocity, operational efficiency, and compliance via data integrity.
ReadL7 Informatics Signs Agreement with ATCC, a Premier Biological Materials Company
L7 Informatics announced that it will begin collaborating with ATCC to help enhance the digitalization of its manufacturing and laboratory operations.
ReadL7 Informatics Releases L7|HUB™ On Top Of Industry-leading Enterprise Science Platform, L7|ESP™
L7 Informatics, Inc is pleased to announce the release of L7|HUB. 7|HUB is a repository of shared digital content for L7|ESP users. L7|ESP is a composable platform where citizen developers can use building-blocks to create more composite processes.
ReadL7|ESP™ to Support Genome Engineering at Washington University
L7 Informatics is honored to announce the roll-out of L7|ESP at the Genome Engineering & iPSC Center (GEiC) at Washington University in St. Louis. The center helps the university's researchers develop cell and animal models using gene editing and stem cell technologies.
ReadSciBite and L7 Informatics Partner to Deliver Data Ontology Search Through L7|ESP™
SciBite and L7 Informatics are pleased to announce a partnership that enables L7 Informatics to deliver ontology management powered by SciBite's CENtree™ software within L7's Enterprise Science Platform (L7|ESP).
ReadData and AI Accelerate Digital Transformation in Pharma
The PDA Annual Meeting emphasized the growing need for pharma manufacturing facilities to become digitalized to improve productivity, open the door to further technologies, and make the most of the ‘digitally native’ workforce.
ReadL7 Informatics Raises $13M in Series B Financing
L7 Informatics announced that it closed its Series B financing round. The financing was supported by previous investors along with several new investors, including Phoenix Venture Partners.
ReadL7 Informatics deploys ESP Software Platform for COVID-19 Workflow at University of Oregon
L7 Informatics announced that it has deployed L7|ESP to automate all lab operations starting with implementing a COVID-19 workflow at the University of Oregon (UO). The L7|ESP workflow supports the high throughput Sar-Cov2 testing via the university's CLIA lab sites.
ReadCognate BioServices, the Leading Biologics CDMO, Selects L7 Informatics to Implement L7|ESP for Integrated Manufacturing and Lab Operations
L7 Informatics announced that it has partnered with CRL's Cognate BioServices, Inc., the premier commercial-ready CDMO in the Cell & Gene Therapy industry, to deploy L7|ESP (Enterprise Science Platform) and implement an integrated manufacturing and lab system.
ReadL7 Informatics Automates Lab Operations and Supports Washington University School of Medicine with Workflow for Its Saliva-based COVID-19 Test
L7 Informatics announced that it has deployed L7 | ESP to automate all lab operations starting with COVID-related workflow at the Genome Technology Access Center (GTAC@MGI) in the McDonnell Genome Institute at the Washington University School of Medicine.
ReadBreaking Down Data Silos in the Lab
How integrated data management systems can support dignostics labs. Vasu Rangadass, Ph.D., President and CEO of L7 Informatics is interviwed by Erica Tennenhouse, Ph.D., Managing Editor of Clinical Lab Manager.
ReadL7 Informatics to deploy ESP in QIAGEN’s Genomics Service Labs to improve laboratory workflows and data management.
L7 Informatics deploys its software platform, Enterprise Science Platform or ESP, in QIAGEN's Genomics Service Labs. Following the installation of ESP, additional development projects are planned to further enhance Sample to Insight workflows across QIAGEN's research and diagnostics portfolios.
ReadL7 Informatics Recognized as a Cool Vendor in the May 2020 Cool Vendors in Life Sciences Report by Gartner
L7 Informatics has been recognized as a 2020 Cool Vendor in Gartner's Cool Vendors in Life Sciences report. L7 is one of only five companies recognized in the Cool Vendors in Life Sciences report.
ReadTaking on the Pandemic: Transforming a Clinical Lab Into a COVID-19 Ready Lab
L7 Informatics Inc.and Contamination Source Identification (CSI) deploy 'ready to go' COVID-19 workflows based on the CDC testing protocol for testing laboratories supporting coronavirus patient screening.
ReadCOVID19 – A Letter to Our Valued Partners
As a company, L7 has taken measures to ensure the health and safety of our employees following the guidelines provided by the CDC and local authorities. Additionally we are working closely with each of our customers to mitigate the impact of travel restrictions on ESP implementations through our virtual delivery model.
ReadUSDA-USMARC Streamlines Research Operations with L7 Informatics NGS LIMS System
L7 Informatics, Inc. is pleased to announce the USDA is now live on their Enterprise Science Platform (ESP). This move will empower better collaboration among all the research stakeholders and streamline research operations for the agency.
ReadSoftware and Analytics Company to Deploy Cutting Edge Platform for Leading Fertility Organization
L7 Informatics announces the completion of the Phase 1 implementation of its Enterprise Scientific Platform (ESP) with CReATe Fertility Centre. The organization was seeking a scientific information management platform to streamline and optimize their genomics testing operations.
ReadInari Agriculture Selects L7 Informatics’ Enterprise Science Platform to Unify Global Operations
Inari, a seed company revolutionizing plant breeding by tapping into natural genetic diversity, selected L7 Informatics, the leader in life + crop science informatics platforms, to integrate Inari's global research data, processes and bioinformatics.
ReadG-CON Manufacturing and L7 Informatics Announce a Collaboration to Develop ESP G-CON smartPOD, the First-of-its-Kind Integrated Cleanroom Software Platform
G-CON Manufacturing, the leader in prefabricated flexible cleanroom solutions and L7 Informatics, the leader in life science process automation software, today announced a collaboration to develop a fully integrated cleanroom and manufacturing software solution to improve biologics manufacturing.
ReadRethinking Data Management to Accelerate Discoveries in Life Sciences
Unlocking the full potential of clinical research and trials, L7 Informatics ushers in a focused way of managing data and solving complex problems in the life sciences world.
ReadGradalis Deploys L7’s Enterprise Science Platform for Next-generation Life Science Companies in Record Time to Support Mission-critical Immunotherapy Manufacturing and Clinical Trial Processes
Gradalis, Inc. announced today it has successfully implemented and launched L7|ESP, a next-generation life sciences platform providing a secure, flexible and scalable technology solution to support cell and CAR-T therapy companies processes and data.
ReadL7 Informatics Releases L7 Enterprise Science Platform 2.0 with Pre-Built Microsoft Genomics Integration
7 Informatics is pleased to announce today the release of Enterprise Science Platform 2.0 (ESP) with a validated pre-built Microsoft Azure connector to the Microsoft Genomics service on the Azure cloud.
ReadLab7 Systems Appoints New CEO and Changes Name to L7 Informatics
Lab7 Systems announced today its name changed to L7 Informatics, Inc. to reflect the expansion of its product offering. In conjunction with the name change, L7 is proud to announce the appointment of Vasudev Rangadass, Ph.D., as its CEO.
Read2017 Recap and Heading Into 2018
2017 ended in a flurry of activities... and 2018 is lining up to be a breakthrough year for Lab7!
Read